Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282355 · ClinicalTrials.gov registry record · NA
Astaxanthin Reduces Exercising Heart Rate.
A NA study, sponsored by University of North Alabama.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT05282355 is a NA study that has completed, run by University of North Alabama. The registered enrollment target is 19 participants.
The verdict
NCT05282355, a NA study, has completed, sponsored by University of North Alabama.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Briefly, this study involved 2 trials: baseline (Trial 1) and post-astaxanthin intervention (Trial 2). Both trials included participants completing a graded exercise test while connected to a metabolic cart, to measure cardiorespiratory measures. Between trials, participants were supplemented with either 12 mg of astaxanthin or placebo for 4 weeks. It was hypothesized astaxanthin supplementation would increase rates of fat oxidation, while decreasing carbohydrate oxidation and blood lactate accumulation.
Interventions
- DIETARY_SUPPLEMENT Astaxanthin
- DIETARY_SUPPLEMENT Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2021-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05282355
The ClinicalTrials.gov registry entry for NCT05282355 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Alabama, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Astaxanthin is the first listed.
NCT05282355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05282355 about?
NCT05282355 is a clinical study titled "Astaxanthin Reduces Exercising Heart Rate.". Briefly, this study involved 2 trials: baseline (Trial 1) and post-astaxanthin intervention (Trial 2). Both trials included participants completing a graded exercise test while connected to a metabolic cart, to measure cardiorespiratory measures. Between trials, participants were supplemented with e...
What is the current status of trial NCT05282355?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-05-12. Estimated completion is 2021-07-02.
What interventions are being tested in trial NCT05282355?
The interventions under investigation include: Astaxanthin (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05282355?
This trial is sponsored by University of North Alabama, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.